TY - JOUR
AU - E. Pfoh
AU - R. Mojtabai
AU - J. Bailey
AU - J. P. Weiner
AU - S. M. Dy
A1 - 
AB - OBJECTIVE: Depression screening is a required part of an initial annual wellness visit (AWV), a benefit for Medicare Part B beneficiaries. It is uncertain whether AWVs will increase depression screening. This study assessed whether patients with an AWV were more likely to be screened for depression than those with a primary care visit. METHODS: A cross-sectional analysis of electronic health record data was conducted for 4,245 Medicare patients who had at least one primary care visit at one of 34 practices within a large multisite provider network between September 2010 and August 2012. Quota sampling was used so that half of the participants had an AWV and half had a randomly selected primary care visit during the study period (the index visit). Multilevel logistic regressions were used to determine whether patients with an AWV had increased odds of depression screening compared with patients with a primary care visit, after adjustment for physician and clinic clustering. RESULTS: Fifteen percent of patients with non-AWVs and 10% of patients with AWVs received depression screening. After accounting for clustering, there was no statistically significant difference in depression screening by visit type. There was a strong site effect, with one site conducting screening during 78% of AWVs and 82% of non-AWVs. Six sites screened none of their patients. CONCLUSIONS: Overall, depression screening during the index AWV was uncommon. By itself, the AWV benefit does not appear to be a strong enough incentive to increase depression screening.
BT - Psychiatric services (Washington, D.C.)
C5 - Healthcare Policy
DO - 10.1176/appi.ps.201400524
JF - Psychiatric services (Washington, D.C.)
N2 - OBJECTIVE: Depression screening is a required part of an initial annual wellness visit (AWV), a benefit for Medicare Part B beneficiaries. It is uncertain whether AWVs will increase depression screening. This study assessed whether patients with an AWV were more likely to be screened for depression than those with a primary care visit. METHODS: A cross-sectional analysis of electronic health record data was conducted for 4,245 Medicare patients who had at least one primary care visit at one of 34 practices within a large multisite provider network between September 2010 and August 2012. Quota sampling was used so that half of the participants had an AWV and half had a randomly selected primary care visit during the study period (the index visit). Multilevel logistic regressions were used to determine whether patients with an AWV had increased odds of depression screening compared with patients with a primary care visit, after adjustment for physician and clinic clustering. RESULTS: Fifteen percent of patients with non-AWVs and 10% of patients with AWVs received depression screening. After accounting for clustering, there was no statistically significant difference in depression screening by visit type. There was a strong site effect, with one site conducting screening during 78% of AWVs and 82% of non-AWVs. Six sites screened none of their patients. CONCLUSIONS: Overall, depression screening during the index AWV was uncommon. By itself, the AWV benefit does not appear to be a strong enough incentive to increase depression screening.
PY - 2015
SN - 1557-9700; 1075-2730
T1 - Impact of Medicare Annual Wellness Visits on Uptake of Depression Screening
T2 - Psychiatric services (Washington, D.C.)
TI - Impact of Medicare Annual Wellness Visits on Uptake of Depression Screening
U1 - Healthcare Policy
U2 - 26174947
U3 - 10.1176/appi.ps.201400524
VO - 1557-9700; 1075-2730
Y1 - 2015
ER -